Nalaganje...
MicroRNA immunomodulating therapeutics
In this issue of Blood, Su et al(1) employ an elegant microRNA (miRNA or miR) conjugation strategy to unleash the potential of targeted miRNA therapeutics, and, as a proof of concept, effectively counteract common inflammatory and myeloid disease states.
Shranjeno v:
| izdano v: | Blood |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966931/ https://ncbi.nlm.nih.gov/pubmed/31945151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004106 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|